PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Lewin, Andrew J.
TI  - Significant HbA1c Reduction With Empagliflozin/Linagliptin Combination
DP  - 2015 Jun 18
TA  - MD Conference Express
PG  - 14--14
VI  - 15
IP  - 4
4099  - http://mdc.sagepub.com/content/15/4/14.1.short
4100  - http://mdc.sagepub.com/content/15/4/14.1.full
AB  - Over a 24-week period, a combination of empagliflozin/linagliptin for the treatment of type 2 diabetes produced significant reductions in HbA1c compared with linagliptin and with empagliflozin 10 mg, but not empagliflozin 25 mg. This randomized trial suggests that this approach could be a more efficient way to achieve glycemic control.